COVID-19 follow-up programs across Europe: an ERS END-COVID CRC survey.

Competing Interests: Conflict of Interest: Stefano Aliberti reports grants from INSMED Incorporated, CHIESI, Fisher & Paykel; royalties from McGraw Hill; consulting fees from INSMED Incorporated, INSMED Italy, INSMED Ireland Ltd, ZAMBON, AstraZeneca UK Limited, CSL Behring GmbH, Grifols, Fondazione Charta, Boehringer Ingelheim, CHIESI, ZCUBE Srl, MENARINI, MSD Italia S.r.l.; lecture honoraria from GlaxoSmithKline Spa; participation on advisory boards for INSMED Incorporated, INSMED Italy, AstraZeneca UK Limited, MSD Italia S.r.l; outside the submitted work. Conflict of Interest: Claudia Valenzuela reports consulting fees and lecture honoraria from Boehringer Ingelheim, Hoffmann-La Roche, Ltd, BMS; travel support from Boehringer Ingelheim, Hoffmann-La Roche, Ltd; participation on advisory boards for Boehringer Ingelheim; outside the submitted work. Conflict of Interest: James Chalmers reports grants from Astrazeneca, Novartis, Boehringer Ingelheim, Insmed, Glaxosmithkline , Gilead Sciences; consulting feeds from Astrazeneca, Insmed, Boehringer Ingelheim, Janssen, Chiesi, Novartis, Glaxosmithkline, Pfizer, Zambon; outside the submitted work. Conflict of Interest: Scott S. Wagers reports consulting fees from Kings College Hospital NHS Foundation Trust, Academic Medical Research, AMC Medical Research BV, Asthma UK, Athens Medical School, Boehringer Ingelheim International GmbH, CHU de Toulouse, CIRO, DS Biologicals Ltd, ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE, European Respiratory Society, FISEVI, Fluidic Analytics Ltd., Fraunhofer IGB, Fraunhofer ITEM, GlaxoSmithKline Research & Dev Ltd, Holland & Knight, Karolinska Institutet Fakturor, KU Leuven, Longfonds, National Heart & Lung Institute, Novartis Pharma AG, Owlstone Medical Limited, PExA AB, UCB Biopharma S.P.R.L., Umeå University, Univ. Hosptial Southampton NHS Foundation Trust, Università Campus Bio-Medico di Roma, Universita Cattolica Del Sacro Cuore, Universität Ulm, University of Bern, University of Edinburgh, University of Hull, University of Leicester, University of Loughborough, University of Luxembourg, University of Manchester, University of Notthingham, Vlaams Brabant, Dienst Europa, Imperial College London, Boehringer Ingelheim, Breathomix, Gossamer Bio, Astrazeneca, CIBER, OncoRadiomics, University of Leiden, University of Wurzburg, Chiesi Pharmaceutical, University of Liege, Teva Pharmacauticals, Sanofi, Pulmonary Fibrosis Foundation, Three Lakes Foundation; outside the submitted work. Conflict of Interest: Merel Hellemons is an Associate Editor of ERJ Open Research. Conflict of Interest: Chris Brightling reports grants and consulting fees from GSK, AZ, Sanofi, Regeneron, Roche, Genentech, Chiesi, Novartis, BI, Mologic, 4DPharma; outside the submitted work. Conflict of Interest: All other authors have nothing to disclose.